Today, some peptides are widely taken as medication: Insulin, for example, is an FDA-approved peptide, as are GLP-1s, the popular weight loss drugs
When GLP-1 binds to receptors in these areas, it activates anorexigenic (appetite-suppressing) neurons whilst inhibiting orexigenic (appetite-stimulating) pathways, contributing to reduced food intake and increased satiety
7 If these treatments do not improve glycemia or if patients stop producing insulin, doctors may prescribe insulin in combination with other drugs to be injected directly by patients
Tirzepatide is intended for patients with: A BMI of 30 or higher, or 27+ with a related medical condition Previous failed attempts at weight management No personal or family history of medullary thyroid cancer Struggles with regulating blood sugar levels A desire for a long-term, medically supervised treatment Its not intended for casual or cosmetic weight loss and should only be used under medical supervision